Company news

Medrx Co., Ltd. news in 2025

Medrx Co., Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Results of MRX-7MLL Phase I a Clinical Trial

May 23, 2025

Summary of Business Results for the First Quarter Ended March 31, 2025 (Consolidated)

May 20, 2025

FDA Acceptance of New Drug Application for MRX-5LBT (“Lydolyte”)

April 2, 2025

Decks in 2025